Best Kinase Inhibitor for myelodysplastic-myeloproliferative diseases
The 2 Kinase Inhibitor options we list for myelodysplastic-myeloproliferative diseases are all Imatinib Mesylate— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for myelodysplastic-myeloproliferative diseases or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 kinase inhibitor drugs we rate for myelodysplastic-myeloproliferative diseases, all are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for myelodysplastic-myeloproliferative diseases; the right choice depends on your situation, so confirm it with your prescriber.
How kinase inhibitor work
Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.
Source: Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf
These are all Imatinib Mesylatein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 kinase inhibitor products
gleevec
PrescriptionFDA-sourced
Gleevec (Imatinib Mesylate) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome, Dermatofibrosarcoma.
Pharmacy pays
From ~$24.81/30· 2 formsimkeldi
PrescriptionFDA-sourced
Imkeldi (Imatinib Mesylate) is a kinase inhibitor used to treat Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome, Dermatofibrosarcoma.
Pharmacy pays
From ~$24.81/30· 2 formsFrequently asked
- What is the best kinase inhibitor for myelodysplastic-myeloproliferative diseases?
- The Kinase Inhibitor options we list for myelodysplastic-myeloproliferative diseases are all Imatinib Mesylate — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which kinase inhibitor drugs treat myelodysplastic-myeloproliferative diseases?
- pharmaranks lists 2 Kinase Inhibitor products used for myelodysplastic-myeloproliferative diseases, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.